Mesirow Institutional Investment Management, Inc. Adma Biologics, Inc. Transaction History
Mesirow Institutional Investment Management, Inc.
- $1.09 Billion
- Q2 2024
A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 1,755,455 shares of ADMA stock, worth $33.5 Million. This represents 1.79% of its overall portfolio holdings.
Number of Shares
1,755,455
Previous 2,609,282
32.72%
Holding current value
$33.5 Million
Previous $17.2 Million
13.96%
% of portfolio
1.79%
Previous 1.6%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
286Shares Held
179MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$356 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$277 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$252 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$171 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$154 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.75B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...